These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 466925)

  • 1. Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise.
    Winer N; Mason WD; Carter CH; Willoughby TL; Kochak GM; Cohen I; Bell RM
    Clin Pharmacol Ther; 1979 Sep; 26(3):315-25. PubMed ID: 466925
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
    Schwartz J; Jackson G; Kates RE; Harrison DC
    Eur Heart J; 1981 Feb; 2(1):31-9. PubMed ID: 7274264
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity.
    Zech PY; Labeeuw M; Pozet N; Hadj-Aissa A; Sassard J; McAinsh J
    Postgrad Med J; 1977; 53 Suppl 3():134-41. PubMed ID: 928260
    [No Abstract]   [Full Text] [Related]  

  • 5. Atenolol and plasma renin concentration in hypertensive patients.
    Amery A; Lijnen P; Fagard R; Reybrouck T
    Postgrad Med J; 1977; 53 Suppl 3():116-20. PubMed ID: 928259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long term comparison between atenolol and a depot form of propranolol hydrochloride on the heart rate and blood pressure at rest and during physical work in normal subjects].
    Wink K; Weisser P
    Arzneimittelforschung; 1980; 30(8):1298-301. PubMed ID: 7192146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration.
    Shanks RG; Carruthers SG; Kelly JG; McDevitt DG
    Postgrad Med J; 1977; 53 Suppl 3():70-3. PubMed ID: 928269
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise.
    Hespel P; Lijnen P; Vanhees L; Fagard R; Amery A
    J Appl Physiol (1985); 1986 Jan; 60(1):108-13. PubMed ID: 3003020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atenolol on ventilatory and cardiac function in asthma.
    Vilsvik JS; Schaanning J
    Br Med J; 1976 Aug; 2(6033):453-5. PubMed ID: 8188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of action of atenolol in man [proceedings].
    Harry JD; Young J
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P-388P. PubMed ID: 901711
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of intravenous administration of atenolol and practolol on resting and exercise-evoked increase in heart rate and cardiac work load in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):27-30. PubMed ID: 838525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
    Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic atenolol treatment and hypertension development in spontaneously hypertensive rats.
    Richer C; Boissier JR; Giudicelli JF
    Eur J Pharmacol; 1978 Feb; 47(4):393-400. PubMed ID: 631188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.
    Mori T; Handa K; Terao Y; Tanaka H; Kiyonaga A; Shindo M; Matsunaga A; Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):387-90. PubMed ID: 1381611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J; Pozet N; McAinsh J; Legheand J; Zech P
    Eur J Clin Pharmacol; 1977 Nov; 12(3):175-80. PubMed ID: 590303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic long-term effects of atenolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Postgrad Med J; 1977; 53 Suppl 3():99-101. PubMed ID: 928275
    [No Abstract]   [Full Text] [Related]  

  • 20. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.